Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN453859 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Neurotrophic Tyrosine Kinase, Receptor, Type 1 (NTRK1) (Tyr791) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- Tyr791
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components.
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome.
Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.
Tokusashi Y, Asai K, Tamakawa S, Yamamoto M, Yoshie M, Yaginuma Y, Miyokawa N, Aoki T, Kino S, Kasai S, Ogawa K
International journal of cancer 2005 Mar 10;114(1):39-45
International journal of cancer 2005 Mar 10;114(1):39-45
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, Hauffa BP, Eils J, Eils R, Brodeur GM, Schweigerer L, Havers W, Eggert A
Oncogene 2005 Jan 6;24(1):165-77
Oncogene 2005 Jan 6;24(1):165-77
Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome.
Flørenes VA, Maelandsmo GM, Holm R, Reich R, Lazarovici P, Davidson B
American journal of clinical pathology 2004 Sep;122(3):412-20
American journal of clinical pathology 2004 Sep;122(3):412-20
Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.
Frattini M, Ferrario C, Bressan P, Balestra D, De Cecco L, Mondellini P, Bongarzone I, Collini P, Gariboldi M, Pilotti S, Pierotti MA, Greco A
Oncogene 2004 Sep 23;23(44):7436-40
Oncogene 2004 Sep 23;23(44):7436-40
TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.
Tacconelli A, Farina AR, Cappabianca L, Desantis G, Tessitore A, Vetuschi A, Sferra R, Rucci N, Argenti B, Screpanti I, Gulino A, Mackay AR
Cancer cell 2004 Oct;6(4):347-60
Cancer cell 2004 Oct;6(4):347-60
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
